COVID-19 Point of Care Serology Test Kits

This effort acquired COVID-19 Rapid Antibody Test Kits and Diagnostics equipment for medical professionals to determine if patients have been infected with COVID-19.  This requirement is for test kits that provide rapid presumptive qualitative detection of antibodies to COVID-19 in human whole blood, serum, or plasma.  These test typically provide Positive/Negative results in a matter of minutes at the test site using fingerstick, whole blood, serum, or plasma samples with increased screening for specific antibody detection.  Rapid Antibody Tests reduce the risk of transmission from infected patients to medical personnel and conserves Personal Protective Equipment (PPE) in the process.

This action used an Urgent and Compelling J&A. This Class J&A applies to contract actions for Rapid Antibody Test Kits, including the development and upgrade of components thereof, that provide Point of Care (POC), serological rapid antibody tests, that screen for IgG and IgM antibodies or total antibody screening, and are manufactured in the U.S.”This Class J&A applies to contract actions for Rapid Antibody Test Kits, including the development and upgrade of components thereof, that provide Point of Care (POC), serological rapid antibody tests, that screen for IgG and IgM antibodies or total antibody screening, and are manufactured in the U.S.

Awarded contract FA8641-20-P-0001 to Axon Connected LLC for 44925.00 on 2020-06-22.